Plasma endotoxin concentrations during cardiac surgery may be related to atherosclerosis

Perfusion

Volumn 15, Issue 5, 2000, Pages 421-426

  Videm, Vibeke ^a,b   Svennevig, Jan L ^c   Fosse, Erik ^c   Mohr, Brit ^c   Aasen, Ansgar O ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; ENDOTOXEMIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART VALVE REPLACEMENT; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INTESTINE ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN DETERMINATION;

AGED; ARTERIOSCLEROSIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CAROTID ARTERIES; ENDOTOXINS; FEMALE; GASTROINTESTINAL DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; ISCHEMIA; LIMULUS TEST; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 0033828733     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910001500503     Document Type: Article

References (19)

1. Plasma kallikrein generation in endotoxemia is abolished by ultra high doses of methyl-prednisolone: In vivo studies in a pig model
2. Endotoxemia associated with cardiopulmonary bypass
3. Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass?
4. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass
5. Perfusion-related factors of endotoxin release during cardiopulmonary bypass
6. Effects of hypothermia on blood endogenous endotoxin levels during cardiopulmonary bypass
7. Increased plasma concentrations of serum amyloid A: An indicator of the acute-phase response after cardiopulmonary bypass
8. Endotoxaemia detected during cardiopulmonary bypass with a modified Limulus amoebocyte lysate assay
9. New aspects concerning the regulation of the post-operative acute phase reaction during cardiac surgery
10. Heparin-coated cardiopulmonary bypass: I. Biocompatibility markers and development of complications in a high-risk population
11. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients
12. Effects of cardiopulmonary bypass on gut blood flow, oxygen utilization, and intramucosal pH
13. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass
14. Circulating endotoxin and cytokines after cardiopulmonary bypass: Differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes
15. The association among gastric mucosal pH, endotoxemia, and low systemic vascular resistance after cardiopulmonary bypass
16. Endotoxins in cardiopulmonary bypass
17. Presence of circulating endotoxins during cardiac operations
18. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease
19. Change in plasma endotoxin titres and endotoxin neutralizing activity in the perioperative period